AMNI — Amniotics AB (publ) Balance Sheet
0.000.00%
- SEK14.64m
- SEK9.00m
Annual balance sheet for Amniotics AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 6.03 | 0.51 | 44 | 9.1 | 8.21 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.983 | 1.57 | 0.758 | 1.74 | 2.28 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 7.37 | 2.48 | 46 | 15.6 | 12.4 |
Net Property, Plant And Equipment | 5.92 | 9.37 | 7.72 | 6.8 | 5.63 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 16.6 | 53.5 | 58.1 | 28.9 | 26.1 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3.71 | 10.7 | 8.56 | 27.4 | 10.5 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 3.71 | 11.3 | 8.56 | 27.4 | 10.5 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 12.9 | 42.2 | 49.5 | 1.48 | 15.5 |
Total Liabilities & Shareholders' Equity | 16.6 | 53.5 | 58.1 | 28.9 | 26.1 |
Total Common Shares Outstanding |